Loading...

Fagron NV

ARSUF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$25.20
$0.00(0.00%)

Fagron NV (ARSUF) Stock Overview

Explore Fagron NV’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.0/100

Key Financials

Market Cap1.8B
P/E Ratio19.81
EPS (TTM)$1.11
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Week$20.03
1 Month$20.24
3 Months$21.50
1 Year Target$23.00

ARSUF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Fagron NV (ARSUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $23.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.81 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-3.93%
Year-to-Date (YTD) Change
N/A
1-Year Change
7.75%
3-Year Change
17.27%
5-Year Change
57.10%
All-Time (Max) Change
-63.29%

Contact Information

https://www.fagron.com
32 8 001 28 80
Venecoweg 20A, Nazareth, 9810

Company Facts

3,828 Employees
IPO DateFeb 21, 2017
CountryBE
Actively Trading

Frequently Asked Questions

;